Dexamethasone Halts Rare Complication of Type 1 Diabetes


| Feb 1, 1997

A new treatment method has been discovered for lipoatrophy, a rare but problematic complication of type 1 diabetes. The condition is an adverse effect of the immune system's interaction with insulin that results in dents in the skin at insulin injection sites. These dents are caused by atrophy of the tissue directly beneath the skin.

Insulin is known to produce allergic and immunological reactions in some people. In such a reaction, the body's immune system attacks the foreign substance, like it would a disease-causing bacteria.

Lipoatrophy is an example of this type of immune system response. It includes the production of cytokines, proteins that work as mediators between the cells in the "infected" area and help generate the response.

In a study published in the November 1996 issue of Diabetes Care researchers hypothesized that the cytokines might also cause the tissue atrophy at injection sites. In laboratory experiments researchers found that dexamethasone, an anti-inflammatory medication, inhibited the production of cytokines.

After these laboratory findings, dexamethasone was used on a 25-year-old woman with lipoatrophy on her arms, abdomen and hips. A mixture of insulin and dexamethasone was injected directly into her lipoatrophic injection sites. This treatment had no effect on the patient's metabolic control and her daily insulin requirements did not change. After 12 months of treatment, all of her lipoatrophic areas disappeared.

Click Here To View Or Post Comments

Categories: Diabetes, Insulin, Medications Research, Type 1 Issues, Type 1 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.